Implementation of uHear™ - an iOS-based application to screen for hearing loss - in older patients with cancer undergoing a comprehensive geriatric assessment

Objective: Validation of uHear (TM) as a screening tool to detect hearing loss in older patients with cancer without a known diagnosis of presbycusis, as part of a Comprehensive Geriatric Assessment (CGA). Materials and Methods: Patients (>= 70 years) with a histologically confirmed diagnosis of cancer, were enrolled at the time of CGA screening. Patients were evaluated by uHear (TM), which was compared to conventional audiometry as gold standard. We defined a pure-tone average (PTA) of >= 40 dB HL as the pass or fail screening cut-off. Validation of uHear (TM) was defined in terms of diagnostic accuracy through Receiver Operating Characteristics (ROC)-analysis. To accept uHear (TM), we estimated that the Area Under the ROC-curve (AUC) had to differ significantly from 0.50 with an AUC of at least 0.70. The Whispered Voice Test and Hearing Handicap Inventory for the Elderly were also administered. Results: Thirty-three patients consented for participation. In one patient, the results of one ear were excluded from the analysis as the patient was documented with a known hearing disorder in that ear. Significant hearing loss, defined by a PTA of >= 40 dB HL calculated from the air conduction thresholds at 0.5,1.0 and 2.0 kHz, was found in 15.4% of tested ears. uHear (TM) showed excellent diagnostic accuracy with an AUC +/- SE of 0.98 +/- 0.14. It provided maximum sensitivity (100.0%) but poor specificity (36.4%) at our predefined cut-off score of >= 40 dB HL. Conclusion: uHear (TM) can be implemented as a screening tool to detect hearing loss in older patients with cancer within a CGA. (C) 2016 Elsevier Ltd. All rights reserved.